Insights on the Effects of Resveratrol and Some of Its Derivatives in Cancer and Autoimmunity: A Molecule with a Dual Activity

被引:53
作者
Gianchecchi, Elena [1 ,2 ]
Fierabracci, Alessandra [2 ]
机构
[1] VisMederi Srl, Str Petriccio & Belriguardo 35, I-53100 Siena, Italy
[2] Childrens Hosp Bambino Gesu, Infectivol & Clin Trials Res Dept, Viale San Paolo 15, I-00146 Rome, Italy
关键词
resveratrol; cancer; autoimmunity; NF-KAPPA-B; TRANS-RESVERATROL; TOPOISOMERASE-II; IN-VITRO; INHIBITS PROLIFERATION; INDUCED APOPTOSIS; OXIDATIVE STRESS; COLON-CANCER; DNA-DAMAGE; LEUKEMIA;
D O I
10.3390/antiox9020091
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In recent years, the interest in natural compounds exerting immunoregulatory effects has enormously increased. Among these, the polyphenol resveratrol, found in a variety of foods and beverages, including red grapes and red wine, has been demonstrated to exert both in vitro and in vivo biological activities. More specifically, it has antiaging, cardioprotective, antioxidant, immunomodulatory, anti-inflammatory and chemopreventive activities. Due to its anti-proliferative, pro-apoptotic and immunoregulatory effects, resveratrol has gained substantial attention for the treatment of cancer or autoimmunity, which represent frequently diagnosed diseases with important consequences for the health of the patients affected. The aim of the present review is to focus on the role of resveratrol in the modulation of cancer as well as of several organ-specific or systemic autoimmune diseases, including autoimmune hepatitis, type 1 diabetes mellitus, inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis.
引用
收藏
页数:16
相关论文
共 129 条
[1]   Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats [J].
Abel Lozano-Perez, Antonio ;
Rodriguez-Nogales, Alba ;
Ortiz-Cullera, Victor ;
Algieri, Francesca ;
Garrido-Mesa, Jose ;
Zorrilla, Pedro ;
Elena Rodriguez-Cabezas, M. ;
Garrido-Mesa, Natividad ;
Utrilla, M. Pilar ;
De Matteis, Laura ;
Martinez de la Fuente, Jesus ;
Luis Cenis, Jose ;
Galvez, Julio .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :4507-4520
[2]   The Hexane Fraction of Bursera microphylla A Gray Induces p21-Mediated Antiproliferative and Proapoptotic Effects in Human Cancer-Derived Cell Lines [J].
Adorisio, Sabrina ;
Fierabracci, Alessandra ;
Gigliarelli, Giulia ;
Muscari, Isabella ;
Cannarile, Lorenza ;
Liberati, Anna Marina ;
Marcotullio, Maria Carla ;
Riccardi, Carlo ;
Curini, Massimo ;
Robles Zepeda, Ramon Enrique ;
Delfino, Domenico V. .
INTEGRATIVE CANCER THERAPIES, 2017, 16 (03) :426-435
[3]  
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[4]   Prooxidant activity of resveratrol in the presence of copper ions: Mutagenicity in plasmid DNA [J].
Ahmad, A ;
Syed, FA ;
Singh, S ;
Hadi, SM .
TOXICOLOGY LETTERS, 2005, 159 (01) :1-12
[5]   Resveratrol Derivative, trans-3,5,4′-Trimethoxystilbene, Exerts Antiangiogenic and Vascular-Disrupting Effects in Zebrafish Through the Downregulation of VEGFR2 and Cell-Cycle Modulation [J].
Alex, Deepa ;
Leong, Emilia Conceicao ;
Zhang, Zai-Jun ;
Yan, Gloria Tse Ho ;
Cheng, Shuk-Han ;
Leong, Chi-Weng ;
Li, Zhen-Hua ;
Lam, Kai-Heng ;
Chan, Shun-Wan ;
Lee, Simon Ming-Yuen .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 109 (02) :339-346
[6]   Pterostilbene Inhibits Breast Cancer In Vitro Through Mitochondrial Depolarization and Induction of Caspase-Dependent Apoptosis [J].
Alosi, Julie A. ;
McDonald, Debbie E. ;
Schneider, John S. ;
Privette, Alicia R. ;
McFadden, David W. .
JOURNAL OF SURGICAL RESEARCH, 2010, 161 (02) :195-201
[7]  
Andlauer W, 2000, DRUG EXP CLIN RES, V26, P47
[8]   Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor [J].
Andreani, Cristina ;
Bartolacci, Caterina ;
Wijnant, Kathleen ;
Crinelli, Rita ;
Bianchi, Marzia ;
Magnani, Mauro ;
Hysi, Albana ;
Iezzi, Manuela ;
Amici, Augusto ;
Marchini, Cristina .
AGING-US, 2017, 9 (02) :508-523
[9]   The resveratrol analogue, 3,4,5,4′-trans-tetramethoxystilbene, inhibits the growth of A375 melanoma cells through multiple anticancer modes of action [J].
Androutsopoulos, Vasilis P. ;
Fragiadaki, Irene ;
Spandidos, Demetrios A. ;
Tosca, Androniki .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) :1305-1314
[10]   Activation of ERK1/2 is required for the antimitotic activity of theresveratrol analogue 3,4,5,4-tetramethoxystilbene (DMU-212) in human melanoma cells [J].
Androutsopoulos, Vasilis Pericles ;
Fragiadaki, Irene ;
Tosca, Androniki .
EXPERIMENTAL DERMATOLOGY, 2015, 24 (08) :632-634